andamanmedical

Singapore: HSA and MFDS Publish Guiding Principles for Clinical Trials of Machine Learning-enabled Medical Devices (MLMD)

Leave a Comment / Regulatory updates, Singapore / By

In support of digital health product innovation, the Health Sciences Authority (HSA), Singapore, collaborated with the Ministry of Food and Drug Safety (MFDS), Korea, to publish guiding principles for conducting clinical trials of machine learning-enabled medical devices (MLMD). This guideline version is effective from 11 December 2024. Core Guiding Principles for MLMD Clinical Trials Clinical […]

Singapore: HSA and MFDS Publish Guiding Principles for Clinical Trials of Machine Learning-enabled Medical Devices (MLMD) Read More »

Singapore: HSA to Launch New SHARE Portal for Medical Device Regulatory Transactions

Leave a Comment / Regulatory updates, Singapore / By

Online medical device transactions and submissions have been conducted via the Medical Device Information and Communication System (MEDICS) with the Health Sciences Authority (HSA), Singapore. On 21 May 2025, an industry briefing session announced the replacement of MEDICS with the Singapore Health Product Access and Regulatory E-System (SHARE). SHARE is a one-stop digital portal for

Singapore: HSA to Launch New SHARE Portal for Medical Device Regulatory Transactions Read More »

Singapore: HSA Notification Re: Official Launch of MDSAP Website

Leave a Comment / Regulatory updates, Singapore / By

An official observer of the Medical Device Single Audit Program (MDSAP) Regulatory Authority Council (RAC), the Health Sciences Authority (HSA), Singapore, informs that the official website has been launched at https://www.mdsap.global/. MDSAP allows a recognized Auditing Organization (AO) to conduct a single regulatory audit of a medical device manufacturer that satisfies the requirements of multiple

Singapore: HSA Notification Re: Official Launch of MDSAP Website Read More »

Singapore: HSA Public Consultation Re: Proposed Exemption from Manufacturer’s Licensing and Product Registration Requirements for AI-SaMD in Public Healthcare

Leave a Comment / Regulatory updates, Singapore / By

The Health Sciences Authority (HSA), Singapore, seeks public consultation on exemptions from manufacturer licensing and product registration requirements for Artificial Intelligence (AI) – Software as Medical Devices (SaMDs) developed by MOH Holdings Pte Ltd (MOHT), Synapxe Pte Ltd (Synapxe), and public healthcare clusters/institutions. Scope of AI-SaMD for Proposed Exemptions Class A and B Developed under

Singapore: HSA Public Consultation Re: Proposed Exemption from Manufacturer’s Licensing and Product Registration Requirements for AI-SaMD in Public Healthcare Read More »

Thailand: Thai FDA Infographic Re: Document Supplementation System for Upgrading Submission Type from Partial (1 or 2) or Abridged to Full CSDT

Leave a Comment / Regulatory updates, Thailand / By

The Thai Food and Drug Administration (FDA), through the Medical Device Control Division, has developed a document supplementation system to facilitate the upgrading of submission types from Partial 1, Partial 2, or Abridged to Full Common Submission Dossier Template (CSDT). This system is accessible via the TFDA’s Skynet platform and aims to streamline the upgrading

Thailand: Thai FDA Infographic Re: Document Supplementation System for Upgrading Submission Type from Partial (1 or 2) or Abridged to Full CSDT Read More »

Vietnam: Relocation of Infrastructure and Medical Device Administration

Leave a Comment / Regulatory updates, Vietnam / By

On May 21, 2025, the Vietnam Ministry of Health issued Notification No. 387/TB-HTTB, officially announcing the relocation of the Infrastructure and Medical Device Administration (IMDA) office. The new IMDA office is now located on the 7th, 8th, and 9th floors of the Ministry of Health’s 9-storey building at Alley 1, Lane 135 Nui Truc, Ba

Vietnam: Relocation of Infrastructure and Medical Device Administration Read More »

Philippines: Department of Health approves the recommendation of Food and Drug Administration to temporarily suspend New Regulatory Fees.

Leave a Comment / Philippines, Regulatory updates / By

The Department of Health (DOH) posted an advisory on its DOH FB page last May 30, 2025, informing the public of its approval for the temporary suspension of FDA New Regulatory Fees. The approved FDA memorandum with Subject: Recommendation to temporarily suspend the implementation of Administrative Order 2024-0016: Implementing Guidelines on the New Schedule of

Philippines: Department of Health approves the recommendation of Food and Drug Administration to temporarily suspend New Regulatory Fees. Read More »

Andaman Medical Joins TMBIA as a Patron Member, Strengthening Commitment to Regulatory Excellence Across Asia-Pacific

Leave a Comment / Events & Other News / By

We’re excited to announce our continued partnership with the Taiwan Medical and Biotech Industry Association (TMBIA) as a proud Patron Member, reinforcing our commitment to advancing medical device innovation across Asia-Pacific markets. A Partnership Built on Shared Vision As one of only 19 Patron Members supporting TMBIA’s mission, Andaman Medical joins an elite group of

Andaman Medical Joins TMBIA as a Patron Member, Strengthening Commitment to Regulatory Excellence Across Asia-Pacific Read More »

Malaysia: MDA Notification: Advisory on the Use of Malaria Test Kits

Leave a Comment / Malaysia, Regulatory updates / By

On March 31, 2025, the World Health Organization (WHO) issued an advisory regarding performance concerns with certain malaria rapid diagnostic test kits (RDTs). WHO has received multiple reports indicating faint positive test lines observed in patients confirmed to have malaria, potentially affecting test reliability across several countries using these kits. In this regard, the Medical

Malaysia: MDA Notification: Advisory on the Use of Malaria Test Kits Read More »

Thailand: The Implementation of the Electronic Certificate System (e-Certificate)

Leave a Comment / Regulatory updates, Thailand / By

On April 17, 2025, the Food and Drug Administration (FDA) recognized the importance of enhancing competitiveness by developing public administration systems to provide efficient services to the public. Therefore, the electronic certificate system (e-Certificate) has been developed to meet the needs of entrepreneurs, allowing them to access services online anytime and anywhere. This initiative aligns with

Thailand: The Implementation of the Electronic Certificate System (e-Certificate) Read More »

Malaysia: Implementation of Conformity Assessment Procedures for Medical Devices Approved by Recognized Countries

Leave a Comment / Malaysia, Regulatory updates / By

On 26 March 2025, the Medical Device Authority (MDA) announced the implementation of Circular Letter No. 1/2025, which supersedes Circular Letter No. 2/2014 regarding conformity assessment procedures for medical devices approved by recognised foreign regulatory authorities. This new circular was approved by the MDA Board and Top Management and took effect on 11 March 2025.

Malaysia: Implementation of Conformity Assessment Procedures for Medical Devices Approved by Recognized Countries Read More »

Malaysia: MDA Seeks Public Comment on Draft Guidelines for Export-Only Medical Devices

Leave a Comment / Malaysia, Regulatory updates / By

The Medical Device Authority (MDA) of Malaysia has released the Second Edition Guidance Document, MDA/GD/0051 April 2025: Medical Device for the Purpose of Export Only, for public comment. This document is intended to replace the previous edition MDA/GD/0051 April 2019: Notification of Export Only Medical Device. The revised guidance provides comprehensive guidance on the procedures and

Malaysia: MDA Seeks Public Comment on Draft Guidelines for Export-Only Medical Devices Read More »

Malaysia: MDA Seeks Public Comment on Draft Guidelines for Importing or Supplying Unregistered Medical Devices Through Special Access Exemptions Application

Leave a Comment / Malaysia, Regulatory updates / By

The Medical Device Authority (MDA) of Malaysia has released the Second Edition Guidance Document, MDA/GD/0043 Mei 2025: Import and/or Supply of Unregistered Medical Devices Under Special Access Exemption Application, for public comment.  This document is intended to replace the previous edition, MDA/GD/0043 May 2020: Special Access – Notification – General Requirements. The revised guidance provides

Malaysia: MDA Seeks Public Comment on Draft Guidelines for Importing or Supplying Unregistered Medical Devices Through Special Access Exemptions Application Read More »

Indonesia: Updated List of Approved Labs for Testing Medical Devices and Health Supplies under SNI ISO/IEC 17025:2017

Leave a Comment / Indonesia, Regulatory updates / By

On 21 April 2025, the Directorate General of Pharmaceuticals and Medical Devices of the Ministry of Health of Indonesia issued a new Circular Letter updating the approved list of laboratories for testing medical devices and health supplies under the SNI ISO/IEC 17025:2017 standard. The updated regulation is detailed in Circular Letter Number HK.02.02/E/673/2025. Key Highlights

Indonesia: Updated List of Approved Labs for Testing Medical Devices and Health Supplies under SNI ISO/IEC 17025:2017 Read More »

Malaysia: MDA Announces Prohibition of Online Sale of Optical Devices and Contact Lenses

Leave a Comment / Malaysia, Regulatory updates / By

On 25 March 2025, the Medical Device Authority (MDA) of Malaysia issued a press release announcing a prohibition on the online sale of optical devices and contact lenses. These products are designated as prescribed medical devices under the Medical Device Act 2012 (Act 737) and the Opticians Act 1991 (Act 469). Only registered opticians or

Malaysia: MDA Announces Prohibition of Online Sale of Optical Devices and Contact Lenses Read More »

Malaysia: Implementation of Medical Device Import Permit 

Leave a Comment / Malaysia, Regulatory updates / By

On 26 March 2025, the Medical Device Authority (MDA) of Malaysia officially announced the implementation of a Medical Device Import Permit (IP) requirement under the Customs (Prohibition of Import) Order 2023. This new regulation mandates that importers obtain an Import Permit for bringing medical devices into Malaysia. The MDA has been designated as the responsible

Malaysia: Implementation of Medical Device Import Permit  Read More »

Malaysia: MDA Announces Transition to Online Product Classification Application & Implementation of Validity Period for Product Classification Letter

Leave a Comment / Malaysia, Regulatory updates / By

On April 8, 2025, the Medical Device Authority (MDA) of Malaysia released two important regulatory updates to enhance efficiency, strengthen compliance, and improve the overall submission process for product classification. These updates are effective starting May 1, 2025. The first update mandates the full transition to online submission for product classification applications. The second introduces

Malaysia: MDA Announces Transition to Online Product Classification Application & Implementation of Validity Period for Product Classification Letter Read More »

Thailand: (Draft) Criteria, Methods, and Conditions on Labeling and Documentation (IFU) for Medical Devices

Leave a Comment / Regulatory updates, Thailand / By

On March 18, 2025, the Ministry of Public Health (MoPH) of Thailand released a draft notification to amend its 2020 regulation on the criteria, methods, and conditions for labeling and documentation of medical devices (B.E. 2563), in alignment with the Medical Device Act B.E. 2551 (2008) and its 2019 amendment. Key Summary: Clause 1 This

Thailand: (Draft) Criteria, Methods, and Conditions on Labeling and Documentation (IFU) for Medical Devices Read More »

Indonesia: Update in the Listing of Healthcare Facilities in the Ministry of Health’s Sectoral Showcase

Leave a Comment / Indonesia, Regulatory updates / By

On March 21, 2025, the Ministry of Health announced an update regarding the listing of healthcare facilities in the Sectoral Showcase of the Electronic Catalogue Version 5. This follows the issuance of Circular Letter Number 6432/KA/03/2025, which outlines the transition process for medical device commodities in the procurement system. According to the circular, medical device

Indonesia: Update in the Listing of Healthcare Facilities in the Ministry of Health’s Sectoral Showcase Read More »

Indonesia: Follow-Up Notification on the Electronic Catalogue Transition to Version 6

Leave a Comment / Indonesia, Regulatory updates / By

On March 20, 2025, the Indonesian government issued a follow-up notification in accordance with Circular Letter No. 9 of 2024 regarding the transition from Electronic Catalogue Version 5 to Version 6. The updated guidance outlines the deactivation of certain commodities from Version 5 and introduces a phased migration to the enhanced Version 6 platform. This

Indonesia: Follow-Up Notification on the Electronic Catalogue Transition to Version 6 Read More »

Philippines: Draft for Comments || Guidelines on the Recall of Authorized Health Products Regulated by the Food and Drug Administration

Leave a Comment / Philippines, Regulatory updates / By

On March 31, 2025, the Food and Drug Administration (FDA) of the Philippines released a draft circular titled “Guidelines on the Recall of Authorized Health Products Regulated by the Food and Drug Administration”.  The draft circular aims to establish effective recall procedures for authorized health products regulated by the FDA in the Philippine market. The

Philippines: Draft for Comments || Guidelines on the Recall of Authorized Health Products Regulated by the Food and Drug Administration Read More »

Philippines: FDA Advisory No. 2025-0368 on Operating Periods of FDA ePortal

Leave a Comment / Philippines, Regulatory updates / By

Register your medical device in the Philippines On March 21, 2025, the Food and Drug Administration (FDA) of the Philippines issued FDA Advisory No. 2025-0368, notifying stakeholders of updates to the operating periods of the FDA ePortal system. This change is part of ongoing system maintenance and upgrades aimed at improving online services and supporting

Philippines: FDA Advisory No. 2025-0368 on Operating Periods of FDA ePortal Read More »

Malaysia: First Edition Guidance Document on Importation of Medical Devices for Re-Export (IRE)

Leave a Comment / Malaysia, Regulatory updates / By

On March 11, 2025, the Medical Device Authority (MDA) of Malaysia released the First Edition Guidance Document MDA/GD/0069 titled “Importation of Medical Devices for Re-Export (IRE).” This document provides clarity on the procedures and requirements for importing medical devices into Malaysia for re-export purposes, covering aspects such as approvals, exemptions, and compliance obligations. Key Highlights

Malaysia: First Edition Guidance Document on Importation of Medical Devices for Re-Export (IRE) Read More »

Indonesia: Temporary Closure of Licensing System During Eid al-Fitr 1446 H Joint Leave

Leave a Comment / Indonesia, Regulatory updates / By

The Ministry of Health of Indonesia has announced a temporary closure of the medical device and Household Health Device (PKRT) licensing system in observance of the Eid al-Fitr 1446 H holiday and collective Joint Leave. From March 28 to April 7, 2025, the following systems will be temporarily unavailable: Medical Device Licensing System: https://regalkes.kemkes.go.id/ Other

Indonesia: Temporary Closure of Licensing System During Eid al-Fitr 1446 H Joint Leave Read More »

Philippines: FDA Temporarily Suspends CDRRHR Telephone Lines Due to Facility Maintenance

Leave a Comment / Philippines, Regulatory updates / By

The Food and Drug Administration (FDA) announces that the telephone numbers for the Center for Device Regulation, Radiation Health, and Research (CDRRHR) are suspended from March 4, 2025, to March 28, 2025, or until the completion of necessary roofing installation at their facilities.  Alternative Contact Methods During this period, stakeholders and the public are advised

Philippines: FDA Temporarily Suspends CDRRHR Telephone Lines Due to Facility Maintenance Read More »

Welcome to Andaman Medical. We are your trusted partner for regulatory affairs and market access in Southeast Asia. 

Whether you are a medical device manufacturer or distributor, our dedicated team is here to help you navigate the complex regulatory landscape and bring your products to market efficiently and compliantly.
Contact Us

Main Pages

Address

ANDAMAN MEDICAL PTE LTD (Registration no. 201524804D)
(Head Office Singapore)
Tampines Junction Business Center
Level 09-02 300 Tampines Avenue 5, Singapore 529653

ANDAMAN MEDICAL PTE LTD
(Registration no. 201524804D)
(Head Office Singapore)
Tampines Junction Business Center Level
09-02, 300 Tampines Avenue 5, Singapore 529653

E-mail Address

sales@andamanmed.com

Phone Number

+60 4566 0200

Andaman Medical ©️ 2025. All rights reserved | Privacy Policy
Scroll to Top

Contact Us


Stay Ahead in Southeast Asia's Medical Device Market!

Subscribe to our Newsletter

Be the first to receive essential updates on regulatory changes, market trends, and industry insights from us!

Andaman Medical - Mar Socials 2025 (11)